Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products 2024-07-18 09:50
Everest Medicines Announces Official Acceptance Granted on NEFECON® Supplementary Application by China National Medical Products Administration 2024-07-18 08:00
CCTV-4 Special Series "New Chapters in the Reform and Opening-up" 2024-07-17 23:09
TUGE Technologies Unveils Advanced vSIM IoT Solutions at MWC 2024, Expanding Global Reach 2024-07-17 20:12
State Grid Shizuishan Power Supply Company: Energizing Qilin Melons to Enhance Farmer Income and Improve Quality 2024-07-17 19:14
State Grid Shizuishan Power Supply Company: Ensuring Safety and Abundant Harvest During the "Sanxia" Season 2024-07-17 19:13
MGM Shenzhen Unveiled: A New Landmark in Coastal Luxury 2024-07-17 16:45
JA Solar Signs UN Women's Empowerment Principles 2024-07-17 15:48
The documentary "Better China Better Life" now is online 2024-07-17 14:43
CGTN: Why is deepening reform so important for China? 2024-07-17 13:48
Continuously shortened negative list for foreign investment unleashes market vitality in China 2024-07-17 11:17
Fosun International Included in S&P Global's Sustainability Yearbook 2024 (China Edition) as Top 1% and Recognized as Industry Mover 2024-07-17 11:16
Flourishing port development reveals China's reform and opening up in new era 2024-07-17 10:56
ST. REGIS HOTELS & RESORTS CELEBRATES PRESTIGIOUS RECOGNITION OF THE ST. REGIS MACAO ON ASIA'S 50 BEST BARS 2024 2024-07-17 10:30
USI Expands Global Footprint: New Completion of Tonala Site in Mexico 2024-07-17 09:55
The Fifth Gulangyu Music Festival Grandly Opens! 2024-07-16 20:54
Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma 2024-07-16 19:29
Guangdong Lychee Tasting Event held in Penang, Malaysia: a journey towards Malaysia-China cherished, golden friendship 2024-07-16 17:30
Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma 2024-07-16 17:10
XTransfer Receives In-Principle-Approval For MPI License from Monetary Authority of Singapore Facilitating Cross-Border Remittances for Local SMEs 2024-07-16 16:03
1 76 77 78 79 80 1247